{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:57:29Z","timestamp":1787698649219,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["9021259205"],"award-info":[{"award-number":["9021259205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113007","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T13:21:53Z","timestamp":1650892913000},"page":"113007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Oleanolic acid combined with olaparib enhances radiosensitization in triple negative breast cancer and hypoxia imaging with 18F-FETNIM micro PET\/CT"],"prefix":"10.1016","volume":"150","author":[{"given":"A-Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113007_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.5604\/17322693.1077713","article-title":"Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches","volume":"67","author":"Nowacka-Zawisza","year":"2013","journal-title":"Post. Hig. Med Dosw"},{"issue":"11","key":"10.1016\/j.biopha.2022.113007_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113007_bib3","first-page":"441","article-title":"Oxygenation status of a transplantable tumor during fractionated radiation therapy","volume":"40","author":"Van Putten","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.biopha.2022.113007_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/genes6040935","article-title":"Epigenetic therapy for solid tumors: highlighting the impact of tumor hypoxia","volume":"6","author":"Ramachandran","year":"2015","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2022.113007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.01.028","article-title":"Radiation-\/hypoxia-induced solid tumor metastasis and regrowth inhibited by hypoxia-specific upconversion nanoradiosensitizer","volume":"49","author":"Liu","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2022.113007_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3892\/or.2013.2510","article-title":"Radiosensitizing effect of oleanolic acid on tumor cells through the inhibition of GSH synthesis in vitro","volume":"30","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113007_bib7","first-page":"1","article-title":"Hypoxia imaging and biological evaluation of the radiosensitizing effect of oleanolic acid","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.biopha.2022.113007_bib8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.molonc.2014.06.008","article-title":"Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells","volume":"8","author":"K\u00f6tter","year":"2014","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113007_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2014.01.016","article-title":"Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence","volume":"346","author":"Shanmugam","year":"2014","journal-title":"Cancer Lett."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113007_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-014-2228-7","article-title":"Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122\/Cyclin G1\/MEF2D axis","volume":"400","author":"Zhao","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2022.113007_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-291X(63)90024-X","article-title":"Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme","volume":"11","author":"Chambon","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2022.113007_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940500904X","article-title":"PARP inhibitors for cancer therapy","volume":"7","author":"Curtin","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.113007_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1667\/0033-7587(2003)159[0283:SARIAO]2.0.CO;2","article-title":"Stress and radiation-induced activation of multiple intracellular signaling pathways","volume":"159","author":"Dent","year":"2003","journal-title":"Radiat. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113007_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10549-018-05079-7","article-title":"A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types","volume":"174","author":"Dinkelborg","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.biopha.2022.113007_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u2018BRCAness\u2019 in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.biopha.2022.113007_bib16","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly (ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2022.113007_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1349-7006.2012.02268.x","article-title":"Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation","volume":"103","author":"Hirai","year":"2012","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.113007_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","article-title":"Targeting DNA damage response in cancer therapy","volume":"105","author":"Hosoya","year":"2014","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113007_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0284185117711474","article-title":"Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography","volume":"59","author":"Kanoto","year":"2018","journal-title":"Acta Radiol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113007_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.biopha.2022.113007_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1442-2050.2011.01209.x","article-title":"Measuring tumor hypoxia with 18F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study","volume":"25","author":"Yue","year":"2012","journal-title":"Dis. Esophagus"},{"issue":"8","key":"10.1016\/j.biopha.2022.113007_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/RLU.0b013e318279fd3d","article-title":"Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET\/CT and immunohistochemical studies in non-small cell lung cancer","volume":"38","author":"Hu","year":"2013","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113007_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejmp.2015.12.006","article-title":"PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer","volume":"32","author":"Chirla","year":"2016","journal-title":"Phys. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2022.113007_bib24","doi-asserted-by":"crossref","first-page":"Si90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57 Suppl 1","author":"Horsman","year":"2016","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.biopha.2022.113007_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fonc.2018.00189","article-title":"Hypoxic signalling in tumour stroma","volume":"8","author":"Laitala","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113007_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0001-3765201620140553","article-title":"Radiation dose determines the method for quantification of DNA double strand breaks","volume":"88","author":"Bulat","year":"2016","journal-title":"An. Acad. Bras. Cienc."},{"issue":"21","key":"10.1016\/j.biopha.2022.113007_bib27","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.3390\/ijms20215366","article-title":"Cordycepin enhances radiosensitivity in oral squamous carcinoma cells by inducing autophagy and apoptosis through cell cycle arrest","volume":"20","author":"Ho","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113007_bib28","first-page":"138","article-title":"Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113007_bib29","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers12071769","article-title":"Zebrafish xenografts unveil sensitivity to olaparib beyond BRCA status","volume":"12","author":"Varanda","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2022.113007_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.686776","article-title":"Clinical, radiometabolic and immunologic effects of olaparib in locally advanced triple negative breast cancer: the OLTRE window of opportunity trial","volume":"11","author":"Schettini","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113007_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.semradonc.2010.06.001","article-title":"Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets","volume":"20","author":"Chalmers","year":"2010","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.biopha.2022.113007_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104683","article-title":"Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer","volume":"153","author":"Deepak","year":"2020","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113007_bib33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2020.09.013","article-title":"An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study","volume":"159","author":"Romero","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"26","key":"10.1016\/j.biopha.2022.113007_bib34","doi-asserted-by":"crossref","first-page":"43356","DOI":"10.18632\/oncotarget.17445","article-title":"The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113007_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pep.2019.04.003","article-title":"Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli","volume":"160","author":"Tsai","year":"2019","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.biopha.2022.113007_bib36","first-page":"2601","article-title":"Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study","volume":"9","author":"Lin","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"9","key":"10.1016\/j.biopha.2022.113007_bib37","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1349-7006.2008.00870.x","article-title":"Cancer cells survive with survivin","volume":"99","author":"Yamamoto","year":"2008","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.biopha.2022.113007_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/1535-7163.MCT-11-0278","article-title":"Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft","volume":"10","author":"Senra","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2022.113007_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2006.02.009","article-title":"Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer","volume":"53","author":"Seto","year":"2006","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2022.113007_bib40","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/00005537-200012000-00017","article-title":"The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma","volume":"110","author":"Guang-Wu","year":"2000","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.biopha.2022.113007_bib41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.116.180422","article-title":"Pharmacokinetic analysis of dynamic 18F-fluoromisonidazole PET data in non-small cell lung cancer","volume":"58","author":"Schwartz","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113007_bib42","doi-asserted-by":"crossref","first-page":"17832","DOI":"10.1038\/s41598-018-36238-x","article-title":"Noninvasive evaluation of 18F-FDG\/18F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2022.113007_bib43","first-page":"1","article-title":"Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET\/CT and overall survival in glioma patients","volume":"47","author":"Hu","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:53:37Z","timestamp":1780487617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"alternative-id":["S0753332222003961"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oleanolic acid combined with olaparib enhances radiosensitization in triple negative breast cancer and hypoxia imaging with 18F-FETNIM micro PET\/CT","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113007"}}